Clincosm LogoSign in Get a demo

AML

Showing 1 - 25 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

AML Trial in Guanzhou (CLAG)

Not yet recruiting
  • AML
  • CLAG
  • Guanzhou, Guangdong, China
  • +1 more
May 16, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

AML, MRD Trial in Shanghai (Azacitidine, Venetoclax, Selinexor)

Not yet recruiting
  • AML
  • MRD
  • Shanghai, China
  • +3 more
Feb 12, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

AML Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • AML
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
  • +1 more
Feb 17, 2023

AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

Recruiting
  • AML
  • Image-based ex-vivo drug screening platform (pharmacoscopy)
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Feb 8, 2023

AML Trial in Beijing (IM23)

Completed
  • AML
  • Beijing, China
    Xian Lu
Jan 18, 2023

Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

MDS, AML Trial in Austria, Germany (CPX-351, Daunorubicin, Cytarabine)

Recruiting
  • MDS
  • AML
  • Linz, Austria
  • +26 more
Sep 9, 2022

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

Not yet recruiting
  • AML
  • Acute Myeloid Leukemia
  • DREAMLAND
  • CERENA
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 12, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

AML Trial in Hannover, Basel (oNKord®, Cyclophosphamide/Fludarabine (Cy/Flu))

Recruiting
  • AML
  • oNKord®
  • Cyclophosphamide/Fludarabine (Cy/Flu)
  • Hannover, Germany
  • +1 more
Aug 3, 2022

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

AML Trial in Hangzhou (CD33 CAR-T)

Not yet recruiting
  • AML
  • CD33 CAR-T
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Jul 21, 2022

MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)

Not yet recruiting
  • MDS
  • AML
  • venetoclax + azacitidine +/- donor lymphocyte infusion
  • Amiens, France
  • +13 more
Jul 21, 2022